118 related articles for article (PubMed ID: 28667362)
1. Quantitative contrast-enhanced CT attenuation evaluation of osseous metastases following chemotherapy.
Chang CY; Simeone FJ; Torriani M; Bredella MA
Skeletal Radiol; 2017 Oct; 46(10):1385-1395. PubMed ID: 28667362
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements.
Ulano A; Bredella MA; Burke P; Chebib I; Simeone FJ; Huang AJ; Torriani M; Chang CY
AJR Am J Roentgenol; 2016 Aug; 207(2):362-8. PubMed ID: 27101076
[TBL] [Abstract][Full Text] [Related]
3. Concordance between fine-needle aspiration and core biopsies for osseous lesions by lesion imaging appearance and CT attenuation.
Li J; Weissberg Z; Bevilacqua TA; Yu G; Weber K; Sebro R
Radiol Med; 2018 Apr; 123(4):254-259. PubMed ID: 29249078
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses.
Elangovan SM; Sebro R
AJR Am J Roentgenol; 2018 Mar; 210(3):615-620. PubMed ID: 29323547
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy.
Gourtsoyianni S; Hwang S; Panicek DM; Zheng J; Moskowitz C; Scher H; Morris M; Hricak H
Br J Radiol; 2012 Sep; 85(1017):1243-9. PubMed ID: 22919006
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
Catalano OA; Nicolai E; Rosen BR; Luongo A; Catalano M; Iannace C; Guimaraes A; Vangel MG; Mahmood U; Soricelli A; Salvatore M
Br J Cancer; 2015 Apr; 112(9):1452-60. PubMed ID: 25871331
[TBL] [Abstract][Full Text] [Related]
7. CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.
Azar A; Garner HW; Rhodes NG; Yarlagadda B; Wessell DE
AJR Am J Roentgenol; 2021 Apr; 216(4):1022-1030. PubMed ID: 32755207
[No Abstract] [Full Text] [Related]
8. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
[TBL] [Abstract][Full Text] [Related]
9. Osseous metastases of chordoma: imaging and clinical findings.
Chang C; Chebib I; Torriani M; Bredella M
Skeletal Radiol; 2017 Mar; 46(3):351-358. PubMed ID: 28064345
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases.
McDonald R; Probyn L; Poon I; Erler D; Brotherston D; Soliman H; Cheung P; Chung H; Chu W; Loblaw A; Thavarajah N; Lang C; Chin L; Chow E; Sahgal A
Technol Cancer Res Treat; 2016 Oct; 15(5):683-8. PubMed ID: 26351302
[TBL] [Abstract][Full Text] [Related]
11. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Macapinlac HA
Radiology; 2008 Apr; 247(1):189-96. PubMed ID: 18372468
[TBL] [Abstract][Full Text] [Related]
12. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
[TBL] [Abstract][Full Text] [Related]
13. Percutane Image-Guided Cryoablation of Painful Osseous Metastases: A Retrospective Single-Center Review.
McArthur TA; Narducci CA; Lander PH; Lopez-Ben R
Curr Probl Diagn Radiol; 2017; 46(4):282-287. PubMed ID: 28034477
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
15. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?
Tochetto SM; Rezai P; Rezvani M; Nikolaidis P; Berggruen S; Atassi B; Salem R; Yaghmai V
Radiology; 2010 Apr; 255(1):164-72. PubMed ID: 20308454
[TBL] [Abstract][Full Text] [Related]
16. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
17. Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.
Skrinskas T; Clemons M; Freedman O; Weller I; Whyne CM
Clin Exp Metastasis; 2009; 26(2):97-103. PubMed ID: 18941910
[TBL] [Abstract][Full Text] [Related]
18. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response.
Huber S; Ulsperger E; Gomar C; Koderhold G; Czembirek H
Anticancer Res; 2002; 22(2B):1279-88. PubMed ID: 12168938
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.
Israel O; Goldberg A; Nachtigal A; Militianu D; Bar-Shalom R; Keidar Z; Fogelman I
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1280-4. PubMed ID: 16791597
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
